BUSINESS MODEL ASSESSMENT

Business Model Assessment: Competitive
AI in Healthcare Ecosystem Mapping

The client, an emerging AI healthcare solutions provider specializing in clinical diagnostic support across multi-specialty settings, partnered with Roots Analysis to execute a comprehensive business model assessment of competing AI platforms globally

Let's Talk

The Challenge

Turning Gaps into Insight and Driving Competitive
Advantage in AI in Healthcare

Incomplete Intelligence on
Rival AI Model Capabilities

The client had established operations across hospitals, diagnostic laboratories and pharmacies; however, it was unable to drive the expected market expansion and associated revenue growth, despite strong operational capabilities and market presence.

Fragmented View of
Competitor Revenue Models

Despite the client tracking competitor announcements and funding rounds, they did not have a clear assessment of how rivals structured their business models, pricing strategies, partnership ecosystems and customer acquisition costs.

Undefined Roadmap for
Technology Differentiation

The client was planning to expand its AI capabilities across multiple clinical applications but lacked clarity on the unmet industry needs and associated features that would strengthen its competitive positioning.

The Roots Way

How Roots Helped?

Roots Analysis deployed an integrated competitive intelligence assessment approach, combining proprietary secondary research with structured business model benchmarking.

Built an AI Ecosystem Framework: The team designed a comprehensive framework that first mapped all leading and emerging AI diagnostic solution providers globally, segmented by clinical specialty, deployment model (cloud-based, on-premise, hybrid), regulatory status and target end-users.

Developed Business Model Profiles: For each competitor, we assembled in-depth profiles documenting core AI algorithms, clinical validation datasets, regulatory pathways pursued, key institutional partnerships, known customer concentration, ongoing R&D initiatives including published research, filed patents and announced feature roadmaps.

Mapped Strategic Gaps & Untapped Opportunities: Using comparative analysis, the team conducted systematic gap assessment to identify underserved clinical applications, unmet user requirements and features that were being offered by competitors. The analysis yielded clear product-level recommendations designed to strengthen competitive positioning.

Change We Created

Results You Can Quantify & Impact
Our Clients Can Count On

35%

Faster Product Development

Through benchmarking and gap analysis, the client prioritized R&D investments in three high-impact AI capabilities representing differentiation opportunities. This strategic focus reduced the product development cycle by 35%, enabling earlier market entry in underserved clinical segments

28%

Pricing Strategy Optimization

Detailed revenue model analysis revealed pricing dynamics across different customer segments. The client adjusted its pricing architecture to achieve a 28% uplift in average customer retention while remaining competitively positioned

22%

Expansion in Portfolio

The landscape assessment identified three previously overlooked clinical specialties where competitor coverage remained fragmented. By redirecting go-to-market efforts toward these, the client expanded its portfolio by 22%